Amaero (3DA) EGM 2025 summary
Event summary combining transcript, slides, and related documents.
EGM 2025 summary
24 Dec, 2025Opening remarks and agenda
Meeting opened at 11:00 A.M. with quorum confirmed and proper constitution acknowledged.
Notice and explanatory memorandum were made available to all members on 28 February 2025.
Meeting held virtually via Zoom using the Automic platform, enabling live participation and voting.
Specific resolutions to be voted on
Ratification of issue of placement shares under ASX Listing Rule 7.4, Tranche 1, to unrelated investors.
Approval to issue placement shares to Pegasus under ASX Listing Rule 10.11, Tranche 2.
Approval to issue ordinary shares to Gen 76ers, Eric Bono, AllCare Investments, and Jamie Levy under ASX Listing Rule 10.11, Tranche 2.
Approval of company name change to Amaro Limited.
Corporate governance
Proxies inspected and all validly lodged proxies accepted; undirected proxies held by the chair will be cast in favor of each resolution.
Samantha Soundara of Automic Group appointed as Returning Officer to conduct the poll.
Latest events from Amaero
- Record revenue growth, strong backlog, and U.S. IPO plans mark a pivotal year.3DA
Q4 2026 TU - Poised for rapid growth, Amaero leads U.S. advanced powder production and targets a U.S. IPO.3DA
IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 - Shareholders and option holders strongly approved all proposed schemes and director option grants.3DA
Scheme Meeting 2026 presentation - Q3 FY2026 revenue up 301%–347% YoY, FY2026 fully contracted, U.S. redomiciliation advances.3DA
Q3 2026 TU - FY2025 saw record revenue, major supply deals, and facility expansion, setting up strong FY2026 growth.3DA
H2 2025 - Strategic U.S. shift, capital raises, and C103 supply deals set path to EBITDA breakeven by FY2026.3DA
H2 2024 - Revenue up 367%, net loss widens, FY2026 guidance cut amid U.S. contract delays.3DA
H1 2026 - Production and revenue scale rapidly with new atomizer, strong contracts, and U.S. market demand.3DA
Status Update - Transition to commercialization, capital raises, and U.S. expansion with new leadership.3DA
AGM 2024